Bacteremia with gram-negative organisms is associated with high mortality and morbidity (29) . The lipopolysaccharide (LPS) component of the outer membrane of these bacteria, known as endotoxin (27) , reproduces much of the pathophysiology associated with gram-negative sepsis (1, 7) . Recently, the correct structure of the toxic portion of LPS, lipid A (27) , has been elucidated ( Fig. 1) (2, 9, 13, (17) (18) (19) (22) (23) (24) . This was greatly facilitated by the discovery of lipid X (Fig. 1) , a novel monosaccharide precursor of lipid A that accumulates in certain phospholipid mutants of Escherichia coli (2, 13, 17, 19, 23, 24) . Discovery of the biologic activities of lipid A precursors and derivatives has rapidly followed (5, 10, 11, 25, 28) . We have found that lipid X isolated from E. coli is mitogenic for murine B cells (18) , clotted the Limulus amebocyte lysate (16) , and caused transient pulmonary hypertension with mild permeability changes in sheep (3; Burhop et al., Fed. Proc. 42:4781, 1983 ). However, even large doses of E. coli lipid X (1,000 ,ug/kg) did not cause lethality or serious morbidity in sheep (3) or mice (see below). Since lipid X is a substructure of lipid A, we hypothesized that it might protect against lethal endotoxemia and examined this possibility in mice.
To test for toxicity of lipid X itself, C57BL/10 mice were challenged with 750, 2,000, or 5,000 jxg intraperitoneally (12 Reed and Muench (20) . The data are shown in Table 1 endotoxin challenge. The 50% protection doses were: 0 h, 140 ,ug; 2 h, 350 jig; 4 h, 520 ,ug; 6 h, 1,100 ,ug. When the data are analyzed by chi-squared analysis, using the Yates correction (lipid-X-treated versus untreated), the differences were highly significant for all time points (P < 0.01).
In another experiment designed to further define the relationship between time of LPS challenge and lipid X administration, mice were given 750 ,ug of lipid X from 72 h before through 4 h after endotoxin challenge with either one or two 100% lethal doses (Table 2) . Control mice received Tris-buffered saline and anesthesia. With the lower endotoxin challenge dose, 81% of mice survived if treated with lipid X from 1 h before through 4 h after LPS challenge. With the higher LPS dose, 41% of mice receiving lipid X from 6 h before endotoxin challenge through 1 h after LPS challenge survived. At both challenge doses of endotoxin, the group of mice that received lipid X shortly after endotoxin challenge showed higher mortality than the group on either side. Perhaps this is because those animals were anesthetized twice within a short time and received the toxic endotoxin challenge before receiving lipid X. After we observed this, eight mice were anesthetized twice within 15 min and given lipid X during the second period of anesthesia. None of these mice died.
Particularly striking was the reversal of lethal endotoxicity at times as late as 6 h after endotoxin challenge, although this was demonstrated only at the lower endotoxin dose. By 4 h after 250 jig of LPS, the mice had stopped normal behavior;
i.e., nesting had stopped, little spontaneous activity occurred, and the animals were shaking. Prevention of lethal endotoxicity by the use of glucocorticoids, prostaglandins, naloxone, pressors, fluid resuscitation, or anti-endotoxin antibody is contingent upon their being given before or shortly after the administration of the endotoxin challenge (4, 6, 8, 12, 14, 15, 26, 30) . Lipid X prevented lethal endotoxicity, even when given 4 to 6 h after endotoxin, but this was not so apparent with 500 ,ug of LPS (Table 2) .
Although the mechanism of protection by lipid X is unknown, the simplest explanation is competition for a common target molecule. Other possibilities include termination of endotoxin action by allosteric or noncompetitive interactions, release of an extra-or intracellular inhibitor(s), or rapid elaboration of a protective substance(s), e.g., protein C (F. B. Taylor, Clin. Res. 42: 566A, 1985) . We are in the process of examining other lipid A precursors for their ability to protect mice against lethal endotoxemia. The data presented offer hope that a specific, nontoxic inhibitor of endotoxin might be found among the endotoxin precursor molecules or their derivatives.
